Highnoon Laboratories Limited (HINOON): Corporate Briefing Notes - By Chase Research

<p></p><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">Highnoon Laboratories Limited (HINOON) reported a net profit of PKR 3.25 billion (EPS: PKR 61.41) in CY24, reflecting a 35% year-on-year increase from PKR 2.40 billion (EPS: PKR 45.35) in CY23.</span></li></ul><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">The sales revenue stood at PKR 23.30 billion compared to PKR 19.42 billion in the same period last year. Management attributed this topline expansion to both price adjustments and volumetric growth. Group net revenue for the year reached PKR 24.63 billion.</span></li></ul><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">During CY24, the company launched 17 new products&mdash;11 in the chronic healthcare segment and six in acute...